InfinityLab Poroshell 120 HILIC Columns
The robustness and reproducibility of HILIC separations on Poroshell columns help to switch from challenging, often MS-incompatible ion pair chromatography and normal phase applications.
*Please see document 5994-4414EN below for important information concerning PEEK-lined hardware.
- HILIC Columns
Product Details
- Superficially porous, 'core-shell' particles that provide improved throughput, shorter equilibration times, and higher resolution
- A scalable family of particles—1.9 μm, 2.7 μm, and 4 μm—enable you to get the best from your methods and instruments
- Separate many polar compound classes by choosing from orthogonal bare silica (HILIC), poly-hydroxy fructan (HILIC-OH5), or zwitterionic (HILIC-Z) phases
- Fully compatible with Agilent InfinityLab deactivator additive, which mproves sensitivity in challenging analyses of phosphorylated and carboxylated compounds with stainless steel LC/MS systems
- Part of the InfinityLab family - designed for ease-of-use and maximum compatibility with Agilent instruments and supplies
- Long column life with uniquely robust 1.9 μm low-dispersion UHPLC columns
- Reduced need for sample preparation due to 2 μm frits on 2.7 μm and 4 μm columns
- UHPLC guard columns to further extend the life of your analytical column
- Enhanced usability, traceability, and security with a preprogrammed ID tag
HPLC & LC Column Selector Tool
A series of tools to help you navigate to the best HPLC column choice for your application.
Essential Supplies Guide for InfinityLab LC Series Instruments
Discover the right supplies for your instrument to achieve peak performance and optimize your LC workflow.
Dr. Stefan Bieber
Managing Director, AFIN-TS GmbH
Our SFC method development strategy always includes stationary phases of Agilent Technologies, Inc. We strongly appreciate the robustness of polar ZORBAX and Poroshell phases, such as ZORBAX Rx-SIL and Poroshell 120 HILIC. They exhibit good selectivity and high separation performance, which is key for successful and efficient method development in SFC. The broad spectrum of available column dimensions has great advantage for the optimization of separations and allows us to adjust the column dimension to obtain the most efficient separations.
View More- Key Literature
-
Agilent InfinityLab Poroshell 120 LC Columns: Novel Superficially Porous Columns
Comparison of two porous particles.
- Selection Guides
- English
- 29 Aug 2023
- 735.11 KB
More Chemistries, More Choices For Solving our Toughest Separation Challenges
The InfinityLab Poroshell 120 family has grown to include 3 particle sizes and 19 chemistries, so you can efficiently separate the widest variety of compounds.
- Posters
- English
- 01 Dec 2022
- 3.44 MB
PEEK-lined hardware notification
Customer notification for PEEK-lined hardware performance.
- Cover Letter
- English
- 08 Dec 2021
- 84.43 KB
- Flyers
- Technical Overviews
- Support
-
PEEK-lined hardware notification
Customer notification for PEEK-lined hardware performance.
- Cover Letter
- English
- 08 Dec 2021
- 84.43 KB
PFAS Analysis in Milk, Infant Formula, and Related Ingredients Using HPLC
Per- and polyfluoroalkyl substances (PFAS) are a large group of anthropogenic chemicals that have been applied in industrial, commercial, and domestic products since the 1950s. Because of their toxicity, persistence, and bioaccumulation potential, PFAS have become global environmental pollutants. Besides the environment, the food chain represents another source of exposure, and the risk related to the presence of PFAS in foods has become of increased interest. Whole milk, infant formula, and ingredients used in infant formula production represent important foodstuffs that require sensitive methods with reporting limits at low parts per billion levels or lower for multiple PFAS. This article summarizes optimization experiments and validation of a complete workflow, including sample preparation and a liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for determination of sixteen priority PFAS analytes listed by the U.S. Food and Drug Administration (FDA).
- 07 Jan 2022